. Average of the relative cell viability results upon treatment with ZA or BPH for 72h, grouped by the mutational status of the cell lines. The differences are most pronounced in the blue marked BRAF mutant group, however, NRAS mutant cell lines were more sensitive to ZA. Data are average +/-SEM from at least 6 independent measurements. Figure S2 . Cell cycle analysis upon treatment with 10µM ZA or BPH was carried out for 72 h. Data are shown average +/-SD from two to three independent experiments.
. Representative pictures from the videomicroscopy measurements of A2058 and VM47 (the two most sensitive cell lines in terms of migration) at 0-and 24-hour time point. Pictures are a part of the original pictures, presenting a small group of cells. While control cells have a higher displacement, cells upon treatment with BPH do not migrate far away. Numbers mark the same cells at hour 0 and hour 24. Numbers with 'a' or 'b' designate the daughter cells of the given cell. Cells without numbers mean that those are not on both of the pictures, as either came from out of the picture or went out from the picture during 24 hours. Pictures on the third column show the merged images of hour 0 (red cells) and hour 24 (green cells). Scale bar means 40µm. (i) K2CO3, NaI, acetone, reflux, followed by column chromatography on silica, eluent dichloromethane -ethanol 9:1 (39%) [1] (ii) 1-bromooctane, ethyl acetate, reflux, followed by column chromatography on silica, eluent ethyl acetate -methanol 9:1 and dichloromethane -ethanol 9:1 (45%) (iii) cc. HCl -H2O 1:1, reflux, evaporation to dryness, washing with acetone (90%) (iv) H3PO3, POCl3, toluene, 95 O C, reflux with cc. HCl -H2O 1:1, evaporation to dryness, recrystallization from water -isopropyl alcohol (70%) [2] n Oct means: (CH3)-(CH2)7 Table S1 . Summary table of data based on the mutational status of the cell lines. First column: percentage of living cells compare to control based on long term (10 days) clonogenic assay results with 1µM treatment. Second column: relative migration decrease (-) or increase (+) upon treatment compared to the control. Third column: relative spheroid volume compared to control with 2µM treatment at the sixth day. Four of the eight cell lines (WM35, WM239, WM3060, MEWO) were not able to generate spontaneously spheroids. Fourth-fifth columns: protein (Akt, Erk) activation changes (decrease, + increase) or no change (0) upon treatment.
